RTTNews | Jun 28, 2021 11:44AM EDT

11:44 Monday, June 28, 2021 (RTTNews.com) - Shares of ReShape Lifesciences Inc. (RSLS) are currently gaining over 20% despite no stock related news to drive the shares.

RSLS is currently trading at $7.28, up $1.28 or 21.33%, on the Nasdaq.

In April, ReShape Lifesciences announced merger with Obalon Therapeutics Inc. (OBLN). Obalon is a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity. ReShape Lifesciences is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.

Read the original article on RTTNews ( https://www.rttnews.com/3205465/reshape-lifesciences-gains-20.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved